| Product NDC: | 0378-6151 |
| Proprietary Name: | MENTAX |
| Non Proprietary Name: | butenafine hydrochloride |
| Active Ingredient(s): | 10 mg/g & nbsp; butenafine hydrochloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-6151 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020524 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19961231 |
| Package NDC: | 0378-6151-46 |
| Package Description: | 1 TUBE in 1 CARTON (0378-6151-46) > 15 g in 1 TUBE |
| NDC Code | 0378-6151-46 |
| Proprietary Name | MENTAX |
| Package Description | 1 TUBE in 1 CARTON (0378-6151-46) > 15 g in 1 TUBE |
| Product NDC | 0378-6151 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | butenafine hydrochloride |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 19961231 |
| Marketing Category Name | NDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | BUTENAFINE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Benzylamine Antifungal [EPC],Benzylamines [Chemical/Ingredient] |